HSD17B1 - hydroxysteroid 17-beta dehydrogenase 1 Gene
Also Known as E2DH; HSD17; EDHB17; EDH17B2; SDR28C1; 17-beta-HSD; 20-alpha-HSD
Species: Homo sapiens
About HSD17B1
This gene has 5 transcripts (splice variants), 186 orthologues and 25 paralogues. Biased expression in placenta (RPKM 41.1), fat (RPKM 4.7) and 11 other tissues.
Summary
This gene encodes a member of the 17beta-hydroxysteroid dehydrogenase family of short-chain dehydrogenases/reductases. It has a dual function in estrogen activation and androgen inactivation and plays a major role in establishing the estrogen E2 concentration gradient between serum and peripheral tissues. The encoded protein catalyzes the last step in estrogen activation, using NADPH to convert estrogens E1 and E2 and androgens like 4-androstenedione, to testosterone. It has an N-terminal short-chain dehydrogenase domain with a cofactor binding site, and a narrow, hydrophobic C-terminal domain with a steroid substrate binding site. This gene is expressed primarily in the placenta and ovarian granulosa cells, and to a lesser extent, in the endometrium, adipose tissue, and prostate. Polymorphisms in this gene have been linked to breast and prostate Cancer. A pseudogene of this gene has been identified. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]
HSD17B1 Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_000413.4 | NP_000404.2 | 17-beta-hydroxysteroid dehydrogenase type 1 isoform 1 |
| NM_001330219.3 | NP_001317148.1 | 17-beta-hydroxysteroid dehydrogenase type 1 isoform 2 |
HSD17B1 Protein Structure
adh_short: short chain dehydrogenase (5 - 172)
- 0
- 100
- 200
- 300
- 328 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
17-beta-hydroxysteroid dehydrogenase type 1 |
|
HSD17B1 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P83303 | HSD17B1 Antibody (YA3048) | WB, IHC-F, IHC-P, ICC/IF, IP | Human |
| HY-P83303A | HSD17B1 Antibody (YA3048)(PBS only) | WB, IHC-F, IHC-P, ICC/IF, IP | Human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Ovarian Disease |
|
|
| Endometriosis |
|
|
| Adenomyosis |
|
|
| 17-Beta Hydroxysteroid Dehydrogenase Iii Deficiency |
|
|
| Prostate Cancer |
|
|
| Cytochrome P450 Oxidoreductase Deficiency |
|
|
| Breast Cancer |
|
|
| Syndromic X-Linked Intellectual Disability Type 10 |
|
|
| Endometrial Cancer |
|
|
| Amelogenesis Imperfecta, Type Ig |
|
|
| Pseudohermaphroditism |
|
|
| Lung Cancer |
|
|
| Ovarian Cancer |
|
|
| Disorder Of Sexual Development |
|
|
| Amelogenesis Imperfecta |
|
|
| Lipoid Congenital Adrenal Hyperplasia |
|
|
| Cryptorchidism, Unilateral Or Bilateral |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Felis catus | HSD17B1 | VGNC | VGNC:67656 |
| Mus musculus | HSD17B1 | MGD | MGI:105077 |
| Bos taurus | HSD17B1 | VGNC | VGNC:29968 |
| Canis familiaris | HSD17B1 | VGNC | VGNC:41800 |
| Macaca mulatta | HSD17B1 | VGNC | VGNC:73528 |
| Rattus norvegicus | HSD17B1 | RGD | RGD:2836 |
| Others | HSD17B1 | NCBI |